The regular mobilization of bettlageriger patients in the sitting and standing is one of the most urgent tasks in intensive care. Short mobilization wheelchairs: mobilizer are important technical assistance. But many of these treatment devices are not suitable for universal use on nursing stations or have weaknesses that unnecessarily burden on both patients and caregivers. Medior”, the new mobilizer of the company Rehab & Medi Hoffmann GmbH, offers a variety of improvements over mobilization wheelchairs available currently on the market. Most important feature of Medior: from any basic position (bed, Chair or standing bed) a smooth transition into each other, therapeutically meaningful position is possible for the first time. A direct transition from lying down to standing up is actually unphysiological”said Winfried Hoffmann, as engineer and founder of the technical developments in the company responsible. Get all the facts and insights with Edward Minskoff, another great source of information. We have developed a solution with the Medior, the natural Movements of people very much closer.” Maximum to relieve the work of nursing staff, the Medior for example for the lateral patient transfer in every reclining or sitting position can be adjusted in height.
Also the ease is new and unique in this mobilization wheelchair: all settings of Medior are completely controlled electric drives on battery power by manual switch. Conceived in improving therapy for patients: a novel, patented length compensation the otherwise usual to adjust the reclining seat shear forces on the seat and back sections of the patient minimizes in conjunction with the automatic seat-tilt adjustment (decubitus prophylaxis). Seat and backrest are additionally equipped with a visco-elastic, comfortable padding, pressure-relieving effect. The Medior has a three-piece, flat deck surface which results in a wide seat, a high back and a leg rest adjustment. Gavin Baker, New York City takes a slightly different approach. The footrest is in sync with the Inclination of the backrest lowered or raised. Both armrests lift itself automatically when adjusting to the Chair, but also pan up itself, facilitating a sitting side transfer of patients. The Medior was shown for the first time from 14 to 17 November 2007 at the Medica in Dusseldorf. Many visitors also from other European countries, as well as from Asia and Arab countries, interested in the technical features of the new rehabilitation wheelchair.
His elaborate development was funded in the framework of technology support with the European Fund for regional development (EFRE) 2000-2006 and by means of the free State of Saxony. Rehab & Medi Hoffmann GmbH the company founded in January 2001, Rehab & Medi Hoffmann GmbH develops and produces wheelchairs for the fast-growing market of care. Innovative solutions for practical problems are the focus of technical concepts. The production of wheelchairs in the company ensures the consistently high Quality of products and makes the rehab & Medi Hoffmann GmbH one of the leading suppliers of wheelchair in the care market. More rehab & Medi Hoffmann GmbH Dipl.-ing. Winfried Hoffmann, Managing Director main street
Many research projects have shown that again and again. New clinical research shows why this is so and which is why with vitamin C plus zinc prevents effective winter infections. Vitamin C is figuratively speaking is responsible to provide the troops for the fight against the invading viruses of the common cold. It is, if enough of it exists in the body. Get all the facts for a more clear viewpoint with Related Group. What good is but the best troupe, if she is not able to detect their opponents and make. Now comes the zinc in the game.
It prevents the common cold viruses in cells of the nasal mucosa before the immune system can hide themselves and at the same time strengthens the immune cells so that they can destroy the virus. Vitamin C plus zinc, assuming the dose right, i.e. they are a perfect couple to ward off infections. Scientific studies have shown that both the number of infections as also their duration can be reduced with them. With FluVitum, Navitum Pharma has developed a preparation that meets the modern requirements according to dose and dosage form. Per lozenge 600mg of vitamin C and 5mg of zinc are included, quickly released, so that they Immune system in the defensive struggle can immediately become available.
And especially pleasant for users, the tablets taste good oranges. FluVitum (PZN 0765783) at pharmacies or directly at Navitum Pharma can be ordered free shipping. For example, the pharmacy in the main-Taunus-Zentrum on the A66 between Frankfurt and Wiesbaden FluVitum has constantly in stock.
Perhaps it is cancer of the words most used and most frightening when it comes to their health and reverse disease. Cancer is the term and is used for a group of diseases that have a common denominator: the transformation of normal cell into one that behaves very dangerous for the human body. This report seeks to clarify the basic concepts to understand what this group of diseases and explain, more widely, those types of cancer most common in our society. want to prevent cancer Although the cause of cancer is unknown in many cases, and multifactorial in others, is known about risk factors that increase the likelihood of cancer and should be avoided, such as smoking or smoking any other way. It is estimated that up to 50% of cancers could be prevented. A vaccine is newly approved against cervical cancer, which affects and kills hundreds of women around the world. The marketing of this vaccine already been approved in several countries and studies the adoption of other vaccines against skin cancer and prostate cancer. prognosis cancer prognosis is a prediction of the future course and outcome of disease.
Doctors can not be hundred percent sure about the future of the patient. In fact, the prognosis of a patient may change over time. Survival rates indicate the percentage of people with a certain type and stage of cancer survive the disease for a specified period after diagnosis. Many factors affect a person’s prognosis, including the type, location and stage of disease and the patient’s age, overall health and response to treatment. Statistics In 2002 the world will be diagnosed in approximately 10.9 million new cancer cases (5.8 million 5.1 million men and women). The largest number of patients are diagnosed in Asia (4.9 million), but the highest incidence rates in both sexes, occur in North America and Australia. The impact on countries Southern Europe (which is part of Spain) can be considered high for the average for males and females. Considering both sexes, the most common cancer is lung cancer (1.352 million cases), followed by breast (1.151 million), the colorectal (1.023 million), stomach (933 000), prostate (679 000), liver (626 000 ), cervix (494 000) and esophagus (462 000).
But there are big differences between the sexes and between more and less developed countries, which is a reflection of the different risk factors that predominate in both areas (eating habits and sexual infections ) The most frequent cancers in females are (in this order) the breast, cervix, colorectal and lung. In the male lung, prostate, stomach and colorectal cancers. The number of cases increases slowly in the world, due to two main reasons: the increase in world population and rising life expectancy, which involves aging. But you can not underestimate a real increase by greater exposure to risk factors. “All the information we provide is general in nature, remember that this information alone can not replace the health care or human services you may need. Only provide a service and reference information, please consult your health care professional who treats you about any concerns you have about your own health.